← Back to Search

Behavioral Intervention

Health Communication Tool + SDoH Screening for Lung Cancer

N/A
Recruiting
Led By Lisa Carter-Bawa, PhD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 50 years to 80 years
20 pack-year smoking history
Must not have
Diagnosed with lung cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post intervention
Awards & highlights

Summary

This trial aims to increase lung cancer screening rates, understanding of effective screening strategies, and reduce lung cancer burden through a tailored health communication & decision support tool combined with social determinants of health (SDoH) screening.

Who is the study for?
This trial is for individuals aged 50-80 who can consent, currently smoke or quit within the last 15 years, have a history of significant smoking (20 pack-years), and have never had lung cancer screening. They must speak and understand English. Those with previous lung screenings or diagnosed with lung cancer are excluded.
What is being tested?
The study tests if adding a Social Determinants of Health (SDoH) assessment and referral process to a community-based educational tool improves lung cancer screening rates compared to just the educational tool alone in at-risk communities.
What are the potential side effects?
Since this trial focuses on education and social assessments rather than medical treatments, there are no direct side effects like those seen with drugs or surgeries. However, participants may experience stress or anxiety related to learning about their health risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 80 years old.
Select...
I have smoked the equivalent of a pack a day for 20 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with lung cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lung cancer screening uptake
Secondary study objectives
Health Literacy
Knowledge of Lung Cancer and Lung Screening
Lung Cancer Fatalism
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Social determinants of health screeningExperimental Treatment2 Interventions
Participants will receive a social determinants of health screening assessment and referral process in addition to the community-based lung cancer screening educational tool.
Group II: Community-based lung cancer screeningActive Control1 Intervention
Participants will receive a community-based lung cancer screening educational tool.

Find a Location

Who is running the clinical trial?

Hackensack Meridian HealthLead Sponsor
134 Previous Clinical Trials
29,823 Total Patients Enrolled
Becton, Dickinson and CompanyIndustry Sponsor
71 Previous Clinical Trials
89,658 Total Patients Enrolled
Lisa Carter-Bawa, PhDPrincipal InvestigatorHackensack Meridian Health
3 Previous Clinical Trials
1,172 Total Patients Enrolled
~0 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top